WallStreetZenWallStreetZen

NASDAQ: OLMA
Olema Pharmaceuticals Inc Stock Ownership - Who owns Olema Pharmaceuticals?

OverviewForecastEarningsRevenueDividendOwnership

Insider buying vs selling

Have Olema Pharmaceuticals Inc insiders been buying or selling?

Buy
Sell
NameRoleDateSharesPriceValue
Bain Capital Life Sciences Investors LLC10% Owner2025-01-08300,000$5.76
$1.73MBuy
G. Walmsley GrahamDirector2024-12-17700,761$6.75
$4.73MSell
G. Walmsley GrahamDirector2024-12-17700,761$6.75
$4.73MBuy
Naseem ZojwallaCHIEF MEDICAL OFFICER2024-12-1614,000$4.87
$68.18kBuy
G. Walmsley GrahamDirector2024-12-13700,761$6.75
$4.73MBuy
G. Walmsley GrahamDirector2024-12-13700,761$6.75
$4.73MSell
Sean BohenPRESIDENT AND CEO2024-12-1155,907$8.66
$484.15kSell
Cyrus HarmonDirector2024-12-117,958$8.66
$68.92kSell
Cyrus HarmonDirector2024-12-11179$9.39
$1.68kSell
Shane William Charles KovacsCH. OPERATING FINANCIAL OFF.2024-12-1117,950$8.66
$155.45kSell

1 of 3

OLMA insiders have bought more... subscribe to Premium to read more.
Net Insider Buy/Sell (L12M) Ownership

Be the first to know when OLMA insiders and whales buy or sell their stock.

OLMA Shareholders

What type of owners hold Olema Pharmaceuticals Inc stock?

Institutional
Insider
Retail
NameHoldSharesValueType
Bain Capital Life Sciences Investors LLC10.93%7,500,000$43.20MInsider
Bain Capital Life Sciences Investors LLC9.97%6,843,954$39.42MInstitution
Paradigm Biocapital Advisors LP9.86%6,764,172$38.96MInstitution
Paradigm Biocapital Advisors LP8.02%5,503,600$31.70MInsider
Bvf Inc7.72%5,295,893$30.50MInstitution
Blackrock Inc6.71%4,605,109$26.53MInstitution
Woodline Partners LP5.11%3,505,893$20.19MInstitution
Deep Track Capital LP5.02%3,442,833$19.83MInstitution
Cormorant Asset Management LP4.77%3,270,544$18.84MInsider
Vanguard Group Inc4.76%3,266,999$18.82MInstitution

1 of 3

OLMA vs Biotech Stocks

TickerInst. %Insider %Net Insider (L12M)Net Insider (L3M)
OLMA72.99%27.01%Net Buying
ABSI59.86%33.21%Net SellingNet Buying
RCKT50.42%49.58%Net SellingNet Selling
YMAB61.42%38.58%Net BuyingNet Buying
AURA81.46%15.26%Net SellingNet Buying
View Top Biotech Stocks

Olema Pharmaceuticals Stock Ownership FAQ

Who owns Olema Pharmaceuticals?

Olema Pharmaceuticals (NASDAQ: OLMA) is owned by 102.61% institutional shareholders, 37.96% Olema Pharmaceuticals insiders, and 0.00% retail investors. Bain Capital Life Sciences Investors LLC is the largest individual Olema Pharmaceuticals shareholder, owning 7.50M shares representing 10.93% of the company. Bain Capital Life Sciences Investors LLC's Olema Pharmaceuticals shares are currently valued at $43.20M.

If you're new to stock investing, here's how to buy Olema Pharmaceuticals stock.
©2025 WallStreetZen
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletter
Stock Tools
Top Performing AnalystsStock ScreenerStock ForecastTrending StocksStrong Buy StocksHighest Earnings StocksBest Dividend Paying StocksStatisticsStock Market SectorsStock Market IndustriesHow to Buy Stocks Online
Stock Ideas
Buy The DipBiggest Stock Gainers TodayBiggest Stock Losers Today52 Week High Stocks52 Week Low StocksMost Active Stocks TodayMost Undervalued StocksBest Penny Stocks to Buy NowBest Stocks Under $5Best Stocks Under $10
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.